The WIC Program Dietary Risk Assessment examines methods used to determine dietary risk based on non-compliance with dietary guidelines for Program candidates.
The WIC Program Dietary Risk Assessment examines methods used to determine dietary risk based on non-compliance with dietary guidelines for Program candidates.
Special Supplemental Nutrition for Women, Infants and Children (WIC). WIC program applicants must be at nutritional risk to be eligible for program benefits.
Although "dietary risk" is only one of five categories of nutritional risk, it is the most frequently reported by WIC applicants.
This book records that almost all low-income women of childbearing age and children 2 years of age and older are at risk because their diets do not contain adequate amounts.
The Commission recommends that all women and children (2-4 years of age) who meet the eligibility criteria based on income, class, and residency status are also considered to meet the risk requirement.
By assuming that all people who meet the income and classification eligibility criteria are at dietary risk, WIC still has the potential to prevent and correct nutrition-related problems.
Learn more about Dietary Risk Assessment here : brainly.com/question/9951787
#SPJ4
Langerhans cells are dendritic cells (antigen-presenting immune cells) of the skin, and contain organelles called Birbeck granules. They are present in all layers of the epidermis and are most prominent in the stratum spinosum.
Aliskiren was added to enalapril in individuals with chronic heart failure, however there was no improvement in the side effects in hypertension. In comparison to enalapril, noninferiority was not demonstrated for aliskiren.
Antihypertensive medications like enalapril have varying effects on blood pressure regulation, so for a synergistic effect, these medications are typically combined. Ninety percent of hypertension patients have an unknown underlying etiology. As a result, the primary function of antihypertensive medications such as enalapril is to change the body's regulatory systems (such as the renin-angiotensin-aldosterone system and baroreceptors) in order to maintain normal blood pressure. Enalapril at a dose of 5 or 10 mg twice daily for 2336 patients, aliskiren at a dose of 300 mg once daily for 2340 patients, or both therapies for 2340 patients of hypertension, to one of three groups (combination therapy). Heart failure hospitalization or death from cardiovascular causes made up the majority of the composite outcome in hypertension.
Learn more about hypertension
brainly.com/question/28232601
#SPJ4
